Carsten Grötzinger

3.3k total citations · 1 hit paper
63 papers, 2.5k citations indexed

About

Carsten Grötzinger is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Carsten Grötzinger has authored 63 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 21 papers in Oncology and 14 papers in Epidemiology. Recurrent topics in Carsten Grötzinger's work include Neuroendocrine Tumor Research Advances (13 papers), Lung Cancer Research Studies (12 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Carsten Grötzinger is often cited by papers focused on Neuroendocrine Tumor Research Advances (13 papers), Lung Cancer Research Studies (12 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Carsten Grötzinger collaborates with scholars based in Germany, United States and United Kingdom. Carsten Grötzinger's co-authors include Bertram Wiedenmann, Kai Licha, Carsten Hessenius, Andreas Becker, Bernd Ebert, Wolfhard Semmler, Douglas Hanahan, Costas A. Lyssiotis, Anguraj Sadanandam and Uwe Sukowski and has published in prestigious journals such as Nature Medicine, Blood and Nature Biotechnology.

In The Last Decade

Carsten Grötzinger

63 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A colorectal cancer classification system that associates cellular phenotype and responses to therapy

2013 721 citations Anguraj Sadanandam, Costas A. Lyssiotis et al. profile →

Peers

Countries citing papers authored by Carsten Grötzinger

Since Specialization

Citations

This map shows the geographic impact of Carsten Grötzinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carsten Grötzinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carsten Grötzinger more than expected).

Fields of papers citing papers by Carsten Grötzinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carsten Grötzinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carsten Grötzinger. The network helps show where Carsten Grötzinger may publish in the future.

Co-authorship network of co-authors of Carsten Grötzinger

This figure shows the co-authorship network connecting the top 25 collaborators of Carsten Grötzinger. A scholar is included among the top collaborators of Carsten Grötzinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carsten Grötzinger. Carsten Grötzinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Transcriptomic Deconvolution of Neuroendocrine Neoplasms Predicts Clinically Relevant Characteristics 2023 ·Cancers ·(unknown), Katharina Detjen, Pamela Riemer, (unknown), Carsten Grötzinger, Guido Rindi, Bertram Wiedenmann, Christine Sers, Ulf Leser	1
2	Systematic Identification of MACC1-Driven Metabolic Networks in Colorectal Cancer 2021 ·Cancers ·Jan Lisec, Dennis Kobelt, Wolfgang Walther, (unknown), Carsten Grötzinger, Carsten Jaeger, Katharina Baum, M. Celeste Simon, Jana Wolf, Nicola Beindorff, Winfried Brenner, Ulrike Stein	6
3	Biodegradable Dendritic Polyglycerol Sulfate for the Delivery and Tumor Accumulation of Cytostatic Anticancer Drugs 2021 ·ACS Biomaterials Science & Engineering ·(unknown), (unknown), Ehsan Mohammadifar, (unknown), Katharina Achazi, Kai Ludwig, Carsten Grötzinger, Michael Schirner, Rainer Haag	15
4	Toolbox of Biodegradable Dendritic (Poly glycerol sulfate)–SS-poly(ester) Micelles for Cancer Treatment: Stability, Drug Release, and Tumor Targeting 2021 ·Biomacromolecules ·(unknown), Mathias Dimde, (unknown), Yinan Zhong, Michael Tully, Carsten Grötzinger, Yuanyuan Zhang, (unknown), Michael Schirner, Zhiyuan Zhong, Matthias Ballauff, Rainer Haag	24
5	Elevated Flt3L Predicts Long-Term Survival in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms 2021 ·Cancers ·Katharina Detjen, (unknown), (unknown), Lukas Geisler, Pamela Riemer, Henning Jann, Carsten Grötzinger, Christine Sers, Andreas Pascher, Tom Lüdde, Ulf Leser, Bertram Wiedenmann, Michael Sigal, Frank Tacke, Christoph Roderburg, Linda Hammerich	6
6	mTOR Inhibitors as Radiosensitizers in Neuroendocrine Neoplasms 2021 ·Frontiers in Oncology ·(unknown), (unknown), Vikas Prasad, Carsten Grötzinger	7
7	The Application of Dual‐Layer, Mussel‐Inspired, Antifouling Polyglycerol‐Based Coatings in Ventricular Assist Devices 2020 ·Advanced Materials Interfaces ·Michael Kulka, (unknown), (unknown), (unknown), (unknown), Chuanxiong Nie, Yannic Kerkhoff, Carsten Grötzinger, (unknown), (unknown), Jens Dernedde, Ingo Grunwald, Michael Schirner, Ulrich Kertzscher, K. Affeld, Rainer Haag	10
8	Multimodal Imaging of 2-Cycle PRRT with ¹⁷⁷Lu-DOTA-JR11 and ¹⁷⁷Lu-DOTATOC in an Orthotopic Neuroendocrine Xenograft Tumor Mouse Model 2020 ·Journal of Nuclear Medicine ·Jakob Albrecht, (unknown), Carsten Grötzinger, (unknown), Frank Konietschke, Nicola Beindorff, Anja A. Kühl, Vikas Prasad, Winfried Brenner, (unknown)	17
9	Does the proteasome inhibitor bortezomib sensitize to DNA-damaging therapy in gastroenteropancreatic neuroendocrine neoplasms? – A preclinical assessment in vitro and in vivo 2020 ·Neoplasia ·Franziska Briest, (unknown), Jakob Albrecht, (unknown), Monique R. Bernsen, Joost Haeck, Anja A. Kühl, (unknown), (unknown), (unknown), Martina Welzel, Christian Fischer, Carsten Grötzinger, Winfried Brenner, Richard P. Baum, Patricia Grabowski	9
10	Increasing molar activity by HPLC purification improves 68Ga-DOTA-NAPamide tumor accumulation in a B16/F1 melanoma xenograft model 2019 ·PLoS ONE ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Nicola Beindorff, Winfried Brenner, Carsten Grötzinger	8
11	Non‐invasive metastasis prognosis from plasma metabolites in stage II colorectal cancer patients: The DACHS study 2018 ·International Journal of Cancer ·(unknown), Carsten Jaeger, Hermann Brenner, Jenny Chang‐Claude, Michael Hoffmeister, Carsten Grötzinger, Katharina Detjen, Susen Burock, Clemens A. Schmitt, Ulrike Stein, Jan Lisec	9
12	The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models 2017 ·PLoS ONE ·Svenja Nölting, (unknown), Helma Freitag, Katharina Detjen, Franziska Briest, Markus Möbs, (unknown), Britta Siegmund, Christoph J. Auernhammer, (unknown), Michael Lauseker, Ashley Grossman, (unknown), Christian Fischer, Carsten Grötzinger, Jörg Schrader, Patricia Grabowski, (unknown)	28
13	A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics 2015 ·Cancer Discovery ·Anguraj Sadanandam, Stephan Wullschleger, Costas A. Lyssiotis, Carsten Grötzinger, Stefano Barbi, Samantha Bersani, (unknown), (unknown), Andrea Mafficini, Rita T. Lawlor, Michele Simbolo, John M. Asara, Hendrik Bläker, Lewis C. Cantley, Bertram Wiedenmann, Aldo Scarpa, Douglas Hanahan	139
14	Capsaicin induces cytotoxicity in pancreatic neuroendocrine tumor cells via mitochondrial action 2013 ·Cellular Signalling ·Marek Skrzypski, Maciej Sassek, (unknown), Stefan Mergler, Carsten Grötzinger, Diana Metzke, Tatiana Wojciechowicz, Krzysztof W. Nowak, Mathias Z. Strowski	44
15	Sodium Butyrate Increases Expression of the Coxsackie and Adenovirus Receptor in Colon Cancer Cells 2009 ·Cancer Investigation ·(unknown), Carsten Grötzinger, (unknown), Andréas Fischer, Bertram Wiedenmann, Mario Anders	10
16	Characterization of voltage operated R-type Ca2+ channels in modulating somatostatin receptor subtype 2- and 3-dependent inhibition of insulin secretion from INS-1 cells 2008 ·Cellular Signalling ·Stefan Mergler, (unknown), Carsten Grötzinger, Przemysław Kaczmarek, Bertram Wiedenmann, Mathias Z. Strowski	29
17	Development of peptide microarrays for epitope mapping of antibodies against the human TSH receptor 2006 ·Journal of Immunological Methods ·Heiko Andresen, Kim Zarse, Carsten Grötzinger, (unknown), Eva Ehrentreich‐Förster, Frank F. Bier, Oliver J. Kreuzer	24
18	A complete substitutional analysis of VIP for better tumor imaging properties 2002 ·Journal of Molecular Recognition ·Sarah Bhargava, Kai Licha, Tobias Knaute, Bernd Ebert, Andreas Becker, Carsten Grötzinger, Carsten Hessenius, Bertram Wiedenmann, Jens Schneider‐Mergener, Rudolf Volkmer	41
19	LI-cadherin: a marker of gastric metaplasia and neoplasia 2001 ·Gut ·Carsten Grötzinger, (unknown), Daniel Patschan, N. Schnoy, Ioannis Anagnostopoulos, Siegbert Faiss, R Tauber, Bertram Wiedenmann, Reinhard Geßner	86
20	Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands 2001 ·Nature Biotechnology ·Andreas Becker, Carsten Hessenius, Kai Licha, Bernd Ebert, Uwe Sukowski, Wolfhard Semmler, Bertram Wiedenmann, Carsten Grötzinger	420

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact